CYRX
Cryoport Inc
17.80$
-1.9%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 54.9% | 55.9% | 55.8% | 58.9% | 49.9% | 48.6% | 58.8% | 58.8% | 62.6% | 62.2% | 61.6% | 60.9% | |
| 5.9% | 4.8% | 5.3% | 5.5% | 6.4% | 6.4% | 5.2% | 5.2% | 33.0% | 32.7% | 35.7% | 35.6% | |
| 46.6% | 47.7% | 47.6% | 50.1% | 38.9% | 37.2% | 34.9% | 34.9% | 54.4% | 53.8% | 52.9% | 52.5% | |
| 4.3% | 4.4% | 4.4% | 4.7% | 6.2% | 6.5% | 4.1% | 4.1% | 4.5% | 4.4% | 5.1% | 4.8% | |
| 2.9% | 2.7% | 2.7% | 2.8% | 3.4% | 3.2% | 3.3% | 3.3% | 3.0% | 3.0% | 2.8% | 2.8% | |
| 14.9% | 11.3% | 11.4% | 6.1% | 7.7% | 7.3% | 3.0% | 3.0% | 2.9% | 2.9% | 2.9% | 2.9% | |
| 19.3% | 20.3% | 20.2% | 20.9% | 25.1% | 24.2% | 20.8% | 20.8% | 18.2% | 18.1% | 18.2% | 18.0% | |
| 46.3% | 48.9% | 49.9% | 53.1% | 40.4% | 42.9% | 43.0% | 43.0% | 33.7% | 34.3% | 35.2% | 35.1% | |
| 4.5% | 4.8% | 5.2% | 7.0% | 8.8% | 9.2% | 10.6% | 10.6% | 4.0% | 28.6% | 29.4% | 29.2% | |
| 0.5% | 0.6% | 0.6% | 2.3% | 3.0% | 2.9% | 2.6% | 2.6% | 0.6% | 24.8% | 24.8% | 25.2% | |
| 2.8% | 2.7% | 2.9% | 2.9% | 3.6% | 3.7% | 1.9% | 1.9% | 1.8% | 2.0% | 2.1% | 2.1% | |
| 37.8% | 39.7% | 40.4% | 41.9% | 26.3% | 26.3% | 26.5% | 26.6% | 24.0% | 0.1% | 0.1% | 0.1% | |
| 53.7% | 51.1% | 50.1% | 46.9% | 59.6% | 57.1% | 57.0% | 57.0% | 66.3% | 65.7% | 64.8% | 64.9% | |
| -58.0% | -67.1% | -70.1% | -86.7% | -105.2% | -107.6% | -109.9% | -109.9% | -87.2% | -90.1% | -91.6% | -93.6% | |
| 4.9% | 5.1% | 5.2% | 5.8% | 7.0% | 7.1% | 7.1% | 7.2% | 6.5% | 6.5% | 6.5% | 6.7% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.